Overview
Employees
201-500
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 17, 2024 | Health | FDA announces recall of heart pumps linked to deaths and injuries | Daniel Chang, Holly K. Hacker | (TNS) KFF Health News A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced Monday. The recall comes years after surgeo... |
| Apr 16, 2024 | FDA announces recall of heart pumps linked to deaths and injuries | A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's most serious recall, the agency announced Monday. The recall comes years after surgeons say they first noticed problems with the HeartMate ... |
| Mar 11, 2024 | Abbott Recalls HeartMate Touch Communication System for Unintentional Pump Start and Stop | Please be aware, this recall is a correction, not a product removal. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Names:... |
| Jan 17, 2024 | Ритм жизни: биороботизированное сердце | Сердце без преувеличения можно назвать одним из самых важных органов. Именно потому проблемы с его функционированием, возникающие ввиду травм или заболеваний, так важно вовремя диагностировать и вылечить. Однако не всегда удается сделать эт... |
| Nov 17, 2023 | Why Abbott Believes Its New Pacemaker Will Help It Capture More Market Share | Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. This follows the late June FDA approval of its Aveir DR system — a dual-chamber... |
| May 7, 2023 | Abbott Receives FDA Approval for World’s First Dual Chamber Leadless Pacemaker | What You Should Know: The U.S. Food and Drug Administration (FDA) approves Abbott’s AVEIR™ dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhy... |
| Sep 16, 2022 | Size Matters When it Comes to Choosing The Right Stent | It doesn’t take long for kids to figure out that people come in all different shapes and sizes and that what differentiates us from one another is what makes us unique. And while we are told from a young age that we are all the same inside—... |
| Oct 13, 2021 | 3 Ways to Address Gender and Racial Bias in Clinical Trials | Jennifer Jones-McMeans, Ph.D., Divisional VP of Global Clinical Affairs at Abbott’s Vascular Business I have dedicated my career to clinical research and making strides to advance modern medicine. In the work I do as a clinical researcher, ... |
| Apr 27, 2021 | Abbott Launches New AI-Powered Coronary Imaging Platform in Europe | What You Should Know: – Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that pro... |
Show more
Reviews 0
FAQ about Abbott
What has the press written about Abbott?
Parsers VC has collected 12 articles mentioning Abbott, among them “Health | FDA announces recall of heart pumps linked to deaths and injuries” (Apr 17, 2024) and “FDA announces recall of heart pumps linked to deaths and injuries” (Apr 16, 2024).
Is Abbott still active?
Yes, Abbott is active; its latest activity on Parsers VC dates from Apr 24, 2025.